Traws Pharma (TRAW) Competitors $1.43 -0.03 (-2.05%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$1.48 +0.05 (+3.15%) As of 07/3/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRAW vs. BDRX, MDCX, RNTX, KZR, NRSN, GRCE, MRNS, MAAQ, ALLK, and DYAIShould you be buying Traws Pharma stock or one of its competitors? The main competitors of Traws Pharma include Biodexa Pharmaceuticals (BDRX), Medicus Pharma (MDCX), Rein Therapeutics (RNTX), Kezar Life Sciences (KZR), NeuroSense Therapeutics (NRSN), Grace Therapeutics (GRCE), Marinus Pharmaceuticals (MRNS), Mana Capital Acquisition (MAAQ), Allakos (ALLK), and Dyadic International (DYAI). These companies are all part of the "pharmaceutical products" industry. Traws Pharma vs. Its Competitors Biodexa Pharmaceuticals Medicus Pharma Rein Therapeutics Kezar Life Sciences NeuroSense Therapeutics Grace Therapeutics Marinus Pharmaceuticals Mana Capital Acquisition Allakos Dyadic International Traws Pharma (NASDAQ:TRAW) and Biodexa Pharmaceuticals (NASDAQ:BDRX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Does the media refer more to TRAW or BDRX? In the previous week, Traws Pharma had 4 more articles in the media than Biodexa Pharmaceuticals. MarketBeat recorded 5 mentions for Traws Pharma and 1 mentions for Biodexa Pharmaceuticals. Biodexa Pharmaceuticals' average media sentiment score of 1.17 beat Traws Pharma's score of 0.33 indicating that Biodexa Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Traws Pharma 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Biodexa Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is TRAW or BDRX more profitable? Biodexa Pharmaceuticals has a net margin of 0.00% compared to Traws Pharma's net margin of -15,245.81%. Company Net Margins Return on Equity Return on Assets Traws Pharma-15,245.81% N/A -193.21% Biodexa Pharmaceuticals N/A N/A N/A Do institutionals & insiders hold more shares of TRAW or BDRX? 8.0% of Traws Pharma shares are held by institutional investors. Comparatively, 17.5% of Biodexa Pharmaceuticals shares are held by institutional investors. 13.6% of Traws Pharma shares are held by company insiders. Comparatively, 0.3% of Biodexa Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, TRAW or BDRX? Traws Pharma has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Biodexa Pharmaceuticals has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Which has stronger earnings and valuation, TRAW or BDRX? Biodexa Pharmaceuticals has higher revenue and earnings than Traws Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTraws Pharma$230K34.57-$166.52M-$32.81-0.04Biodexa Pharmaceuticals$470K67.33-$7.32MN/AN/A SummaryBiodexa Pharmaceuticals beats Traws Pharma on 7 of the 10 factors compared between the two stocks. Get Traws Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for TRAW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRAW vs. The Competition Export to ExcelMetricTraws PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.07M$2.43B$5.55B$9.05BDividend YieldN/A1.78%5.24%4.01%P/E Ratio-0.049.1027.6120.23Price / Sales34.57680.44417.23118.52Price / CashN/A158.5936.8958.10Price / Book-0.174.588.035.67Net Income-$166.52M$31.34M$3.18B$249.21M7 Day PerformanceN/A3.25%2.93%3.28%1 Month Performance-3.38%7.08%3.75%5.55%1 Year PerformanceN/A0.17%35.20%21.09% Traws Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRAWTraws Pharma0.1914 of 5 stars$1.43-2.1%N/AN/A$8.07M$230K-0.0417News CoverageBDRXBiodexa Pharmaceuticals0.7104 of 5 stars$0.92+0.3%N/AN/A$33.73M$470K0.0020Positive NewsUpcoming EarningsMDCXMedicus Pharma2.2666 of 5 stars$2.45+4.7%$23.50+859.2%N/A$33.25MN/A-2.11N/AAnalyst ForecastRNTXRein TherapeuticsN/A$1.47-2.0%N/AN/A$32.57MN/A-0.519KZRKezar Life Sciences4.2039 of 5 stars$4.43+4.0%$39.50+791.6%-21.3%$32.38M$7M-0.4160NRSNNeuroSense Therapeutics1.7086 of 5 stars$2.31+8.5%$14.00+506.1%+44.7%$31.58MN/A-4.2810GRCEGrace Therapeutics1.769 of 5 stars$3.00+2.4%$12.00+300.0%N/A$30.42MN/A-2.59N/APositive NewsMRNSMarinus Pharmaceuticals2.3525 of 5 stars$0.55-0.2%$3.92+613.3%-54.6%$30.32M$30.99M-0.22110News CoverageMAAQMana Capital AcquisitionN/A$3.70-0.3%N/A+603.6%$30.06MN/A0.001ALLKAllakos2.8846 of 5 stars$0.33flat$2.00+507.7%N/A$29.74MN/A-0.16190DYAIDyadic International2.0196 of 5 stars$0.99+5.1%$6.00+508.6%-37.1%$29.66M$3.49M-4.937News CoverageGap Up Related Companies and Tools Related Companies Biodexa Pharmaceuticals Competitors Medicus Pharma Competitors Rein Therapeutics Competitors Kezar Life Sciences Competitors NeuroSense Therapeutics Competitors Grace Therapeutics Competitors Marinus Pharmaceuticals Competitors Mana Capital Acquisition Competitors Allakos Competitors Dyadic International Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRAW) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRAW Stock Alerts